超越黑白:种族群体内的癌症差异
Davidi Tawfiles1, Mutlay Sayan2, Brandon A Mahal3
1University of Pennsylvania, Philadelphia, PA, USA.
Journal of general internal medicine
|September 19, 2025
概括
美国癌症数据中的广泛种族类别掩盖了显著的种族差异,阻碍了有效的公共卫生干预. 分解数据对于精确的公共卫生和解决不同人口中的癌症不平等至关重要.
科学领域:
- 公共卫生 公共卫生
- 癌症研究 癌症研究
- 健康差异 在健康上的差异
背景情况:
- 在美国,癌症发病率的种族和民族差异得到了充分证实.
- 当前的数据系统使用广泛的种族分类 (例如",白人"",黑人"",亚洲人"),掩盖了重要的亚组差异.
- 这种聚合掩盖了临床上显著的异质性,并使公共卫生中的结构隐形性永久化.
研究的目的:
- 论证癌症数据中的广泛种族分类掩盖了关键的亚组差异.
- 为了说明种族分类如何揭示癌症发病率和病期的显著差异.
- 突出数据改革的必要性,以支持精确的公共卫生和解决癌症不平等问题.
主要方法:
- 分析国家数据库,如监测,流行病学和最终结果 (SEER) 和国家癌症数据库 (NCDB).
- 审查地方和区域研究,检查特定种族子群体的癌症结果.
- 考察广泛的种族分类对各种公共卫生工作的影响.
主要成果:
- 亚裔美国人亚组之间的种族分类揭示了癌症发病率和癌症阶段的明显差异.
- 在黑人,西班牙裔/拉丁裔和白人 (例如,非洲移民,波多黎各人,阿拉伯美国人) 之间存在不同的癌症结果.
- 这些差异仍然隐藏在国家监督系统中,影响了定制干预措施.
结论:
- 精确的公共卫生需要分类数据,以使多样化的人口可见,并解决癌症差异.
- 改革健康数据系统,将中东和北非 (MENA) 人口纳入一个独特的类别,是必不可少的.
- 解决癌症不平等问题需要文化谦卑,语言包容性和以公平为中心的研究框架.
相关概念视频
01:21Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
02:18Cancer
53.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K
02:59Cancer Prevention
7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.7K
02:53Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
01:20Comparing the Survival Analysis of Two or More Groups
561
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K